| PAMCX | VSCRX | PAMCX / VSCRX | |
| Total Expense Ratio | 1.02 | 0.92 | 111% |
| Annual Report Gross Expense Ratio | 1.02 | 0.92 | 111% |
| Fund Existence | 26 years | 12 years | - |
| Gain YTD | 4.658 | 10.180 | 46% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 2500000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 22.9B | 1.83B | 1,253% |
| Annual Yield % from dividends | 0.00 | 0.51 | - |
| Returns for 1 year | -0.37 | -5.50 | 7% |
| Returns for 3 years | 0.15 | 13.99 | 1% |
| Returns for 5 years | -20.68 | 6.27 | -330% |
| Returns for 10 years | 31.10 | 144.88 | 21% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IHE | 100.96 | 2.67 | +2.72% |
| iShares US Pharmaceuticals ETF | |||
| CCOR | 26.08 | 0.54 | +2.13% |
| Core Alternative Capital | |||
| OPP | 7.70 | 0.03 | +0.39% |
| RiverNorth/DoubleLine Strategic Opportunity Fund | |||
| DVXP | 25.00 | N/A | N/A |
| WEBs Consumer Staples XLP Dfnd Vol ETF | |||
| SMOX | 30.15 | -0.23 | -0.75% |
| Horizon Small/Mid Cap Core Equity ETF | |||